Table 2.

Expression of markers and survival.

			Tumor				Peritumoral capsule
Marker expression	Patients (n)	Patients (%)	Median survival (months)	5-Year survival (%)	P	Patients (n)	Patients (%)	Median survival (months)	5-Year survival (%)	P
CD 3
Low	56	70	80	54	0.207	29	36	32	47	0.756
High	19	24	27	36		40	50	67	56
Missing	5	6				11	14
CD 4
Low	64	80	57	49	0.887	45	56	52	51	0.654
High	14	18	27	50		35	44	57	53
Missing	2	3				10	12
CD 8
Low	64	80	80	54	0.198	47	59	67	52	0.838
High	14	18	15	36		26	32	38	50
Missing	2	3				7	9
CD 20
Low	56	70	63	50	0.880	65	81	75	55	0.032
High	22	28	32	50		12	15	13	33
Missing	2	3				3	4

Peritumoral capsule lymphocyte subsets and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), N = 80